Popular
This Week This Month
Storyboards
Sign In
to Vote &
Create Storyboards.
 

Women with ovarian cancer gain extra months with addition of drug to standard chemotherapy

Science Daily - 28 Mar 2015 16:24
Overall survival for women who received standard chemotherapy treatment plus bevacizumab was a median five months longer than for women who received the standard chemotherapy treatment alone.
Full Article at Science Daily

More Science News
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}     {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}

    • Create Storyboard